Valproic Acid News and Research

RSS
Valproic Acid is a drug used to treat epileptic seizures and bipolar disorder and to prevent migraine headaches. It is also being studied in the treatment of Kaposi sarcoma. It is a type of anticonvulsant, antimaniacal, and migraine headache prophylactic.
Alzheimer's patients using antiepileptic drugs have twice the risk of pneumonia, study shows

Alzheimer's patients using antiepileptic drugs have twice the risk of pneumonia, study shows

Scientists reprogram mature inhibitory neurons into dopaminergic cells

Scientists reprogram mature inhibitory neurons into dopaminergic cells

Research suggests link between epilepsy and bipolar disorder

Research suggests link between epilepsy and bipolar disorder

Valproic acid exposure results in characteristics linked to autism, zebrafish study shows

Valproic acid exposure results in characteristics linked to autism, zebrafish study shows

Scientists genetically engineer mice that display behavioral hallmarks of human bipolar disorder

Scientists genetically engineer mice that display behavioral hallmarks of human bipolar disorder

Study identifies potential link between genes and treatment response in children with CAE

Study identifies potential link between genes and treatment response in children with CAE

Rare antibiotic compound detected in fungi for first time

Rare antibiotic compound detected in fungi for first time

AES releases new guideline to help physicians treat status epilepticus patients effectively

AES releases new guideline to help physicians treat status epilepticus patients effectively

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

UCI researchers uncover new underlying factor of seizures

UCI researchers uncover new underlying factor of seizures

Antiepileptic monotherapy does not increase intrauterine death risk

Antiepileptic monotherapy does not increase intrauterine death risk

Helsinn's Akynzeo for CINV prevention receives EC approval

Helsinn's Akynzeo for CINV prevention receives EC approval

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Vagus nerve stimulation effective in inhibiting cortical spreading depression

Vagus nerve stimulation effective in inhibiting cortical spreading depression

DNMT1 gene essential to maintain breast and cancer stem cells

DNMT1 gene essential to maintain breast and cancer stem cells

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

UV researchers study neurobiological link between ASD and epilepsy

UV researchers study neurobiological link between ASD and epilepsy

Death risk is higher for dementia patients who take antipsychotic drugs, new study shows

Death risk is higher for dementia patients who take antipsychotic drugs, new study shows

Transition Therapeutics presents Phase 2 study of ELND005 drug for bipolar disorder

Transition Therapeutics presents Phase 2 study of ELND005 drug for bipolar disorder

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.